戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 h altered signaling events downstream of the erythropoietin receptor.
2 ivated JAK2 to induce phosphorylation of the erythropoietin receptor.
3 0(5) units/ml on cells that also express the erythropoietin receptor.
4  replaced with the cytoplasmic domain of the erythropoietin receptor.
5 lls engineered to coexpress Mpl receptor and erythropoietin receptor.
6 mutations of the SHP-1 binding domain of the erythropoietin receptor.
7 ge-restricted genes, including Klf1/Eklf and Erythropoietin receptor.
8 ed blood cells-that is caused by a truncated erythropoietin receptor.
9 ch as glucose and anion transporters and the erythropoietin receptor.
10  toward early differentiation with increased erythropoietin receptor.
11 lical dimerization motif found in the murine erythropoietin receptor.
12 tions between transferrin receptor-2 and the erythropoietin receptor.
13 gh its ability to transduce signals from the erythropoietin receptor.
14 his is similar to the K(d) of SOCS-3 for the erythropoietin receptor.
15 d virus envelope glycoprotein, gp55, and the erythropoietin receptor.
16 ytokine receptors such as growth hormone and erythropoietin receptors.
17                          The precise role of erythropoietin receptor-activated (EpoR-activated) Stat5
18                                      Lack of erythropoietin receptor affects brain development as ear
19  high doses (50 mug/kg i.p.) of an exogenous erythropoietin receptor agonist in an inflammation-induc
20 ed whether a novel, synthetic, peptide-based erythropoietin-receptor agonist (Hematide, Affymax) can
21  treated them with a synthetic peptide-based erythropoietin-receptor agonist.
22 ther investigated in mice expressing minimal erythropoietin receptor alleles.
23  containing the intracellular portion of the erythropoietin receptor allowed cells normally dependent
24 FFV envelope glycoprotein interacts with the erythropoietin receptor and a short form of the receptor
25 as been proposed for the activation of human erythropoietin receptor and human growth hormone recepto
26 and negatively regulates signalling from the erythropoietin receptor and is likely to regulate other
27 , the thrombopoietin receptor (MPL), and the erythropoietin receptor and mutations of other genes inv
28 tracellular and transmembrane domains of the erythropoietin receptor and of the intracellular domain
29 ecies barrier exists between mouse and human erythropoietin receptor and that the human erythropoieti
30 hromosome 19p13.2/3, near genes encoding the erythropoietin receptor and the cytokine receptor-associ
31 trast to the acquired MPDs, mutations of the erythropoietin receptor and thrombopoietin receptor have
32 ociate with the IL-3 receptor beta chain and erythropoietin receptor and to inhibit signaling mediate
33 teraction of the viral protein gp55 with the erythropoietin receptor, and other host factors, drives
34 n receptor subunits, sucrase-isomaltase, the erythropoietin receptor, and two of the subunits of the
35 nic lethality in the erythropoietin(-/-) and erythropoietin receptor(-/-) animals.
36  mice, while it has no effect in hearts from erythropoietin receptor(-/-) animals.
37  of human erythroblasts with mouse antihuman erythropoietin receptor antibody but not mouse immunopur
38                      Although high levels of erythropoietin receptor are produced in embryonic brain,
39 425 and 367 in the cytoplasmic domain of the erythropoietin receptor are required for the phosphoryla
40 -CSFR fused to the cytoplasmic domain of the erythropoietin receptor, are able to support the product
41                             Specifically, an erythropoietin receptor-based dimerization assay was use
42                    This novel agonist of the erythropoietin receptor can correct anemia in patients w
43 -9R alpha-chain, IL-2 receptor ss-chain, and erythropoietin receptor, can be polyubiquitinated and de
44 be immunoprecipitated by an antiserum to the erythropoietin receptor carboxyl-terminal domain.
45 2R beta with either gamma c or the truncated erythropoietin receptor chain led to an array of specifi
46 sion systems: 1) 32D cells expressing leptin/erythropoietin receptor chimeras, 2) COS-7 cells express
47 R) signaling complex by a severely truncated erythropoietin receptor cytoplasmic domain lacking tyros
48                           We report that the erythropoietin receptor cytosolic juxtamembrane region i
49  extracellular ligand-binding domains of the erythropoietin receptor, determined at 1.9 A from two cr
50 ivation while preventing JAK2 V617F-promoted erythropoietin receptor dimerization.
51 al regulator of erythropoiesis, cell surface erythropoietin receptors dimerize and activate specific
52 n the extracellular dimerization site of the erythropoietin receptor, distant from the hormone bindin
53                   In studies to identify the erythropoietin receptor domains required for activation
54                      Erythropoietin(-/-) and erythropoietin receptor(-/-) embryos also suffered from
55                 Both erythropoietin(-/-) and erythropoietin receptor(-/-) embryos suffered from ventr
56                               Other modes of erythropoietin receptor (EPO-R) activation, such as inte
57 ning progressively truncated isoforms of the erythropoietin receptor (EPO-R) and determined the rate
58 d tyrosine phosphorylation of both c-kit and erythropoietin receptor (EPO-R) and significantly greate
59             Kit receptor tyrosine kinase and erythropoietin receptor (Epo-R) cooperate in regulating
60                        Signaling through the erythropoietin receptor (EPO-R) is crucial for prolifera
61                           Stimulation of the erythropoietin receptor (EPO-R) or the interleukin-2 rec
62                We previously found increased erythropoietin receptor (EPO-R) protein levels in vigoro
63  expression of erythroid genes including the erythropoietin receptor (EPO-R) that results in increase
64 e cytokine erythropoietin (EPO), its cognate erythropoietin receptor (EPO-R), and associated Janus ty
65 n vivo requires collaboration between c-Kit, erythropoietin receptor (Epo-R), and GATA-1.
66 93T cells heterologously expressing TRPC and erythropoietin receptor (Epo-R), Epo stimulated an incre
67                                       In the erythropoietin receptor (Epo-R), two such motifs (box1 a
68 Here we show that erythroid progenitors from erythropoietin receptor (Epo-R)-/- fetal livers, infecte
69 at bind to the extra-cellular portion of the erythropoietin receptor (EPO-R).
70 uracil-treated mice expressing a compromised erythropoietin receptor EPOR-HM allele.
71 rosine residue (pY) peptide derived from the erythropoietin receptor (EpoR pY429) binds to the N-SH2
72                    To understand the role of erythropoietin receptor (EpoR) activation in erythroid d
73                        Here we show that the erythropoietin receptor (EPOR) acts as a critical switch
74 protein, SFFV gp55, forms a complex with the erythropoietin receptor (EpoR) and a short form of the r
75                    Endothelial cells express erythropoietin receptor (EpoR) and are responsive to ery
76 failing signal transduction at the homomeric erythropoietin receptor (EpoR) and at the heteromeric in
77 displays 100-fold increased affinity for the erythropoietin receptor (EPOR) and correspondingly eleva
78  Here, to clarify the functional role of the erythropoietin receptor (EpoR) and its downstream transc
79  Ba/F3 and B6SUtA cells transfected with the erythropoietin receptor (EpoR) and selected with erythro
80 ceptors with the extracellular domain of the erythropoietin receptor (EpoR) and the cytoplasmic domai
81  whether or not tyrosine residues within the erythropoietin receptor (EPOR) are essential for biologi
82     Here, we show that ubiquitination of the erythropoietin receptor (EpoR) at Lys(256) is necessary
83 a model involves mitogenic activation of the erythropoietin receptor (EpoR) by the virus env gene (F-
84                   Inherited mutations in the erythropoietin receptor (EPOR) causing premature termina
85 2/p30) that are hyperphosphorylated in a DA3/erythropoietin receptor (EpoR) cell line that expresses
86 rythropoiesis, we investigated its action on erythropoietin receptor (EpoR) cellular dynamics.
87 lls, we employed a prolactin receptor (PrlR)/erythropoietin receptor (EpoR) chimera system, in which
88                The cytoplasmic domain of the erythropoietin receptor (EpoR) contains a membrane-dista
89 ane targeted chimeric protein containing the erythropoietin receptor (EpoR) cytoplasmic domain fused
90                                              Erythropoietin receptor (EpoR) dimerization is an import
91 n) scaffold, that can systematically control erythropoietin receptor (EpoR) dimerization orientation
92 e cytokine known to regulate erythropoiesis, erythropoietin receptor (EpoR) expression and associated
93 unoblotting and immunostaining have reported erythropoietin receptor (EpoR) expression in nonhematopo
94   In this issue of Blood, Li et al show that erythropoietin receptor (Epor) expression marks the cent
95 Western blotting was used to detect AT1R and erythropoietin receptor (EpoR) expression.
96 om the anemic strain (gp55-A), activates the erythropoietin receptor (EpoR) for proliferation of hema
97 tor receptor (fgfr-1), and downregulation of erythropoietin receptor (EpoR) gene expression.
98 any cancer cells show some expression of the erythropoietin receptor (EPOR) gene, although the "funct
99 utation affecting codon 399 in exon 8 of the erythropoietin receptor (EPOR) gene, encoding an EpoR pe
100 f red cell production through agonism of the erythropoietin receptor (EpoR) has historically been acc
101 able to bind to one of the 2 subunits of the erythropoietin receptor (EpoR) homodimer and is thus a c
102                                              Erythropoietin receptor (EpoR) homodimerization is an in
103 ated with mutations in the gene encoding the erythropoietin receptor (EpoR) in a small number of fami
104 O) is used to treat anemia by activating the erythropoietin receptor (EPOR) in erythroid progenitor c
105             To elucidate the role of Epo and erythropoietin receptor (EpoR) in melanoma, we examined
106 L traptamers) that specifically activate the erythropoietin receptor (EPOR) in mouse cells to confer
107                    Ectopic expression of the erythropoietin receptor (EpoR) in the interleukin-3 (IL-
108                                          The erythropoietin receptor (EPOR) is a member of a family o
109                                          The erythropoietin receptor (EPOr) is activated by ligand-in
110                   Signal transduction by the erythropoietin receptor (EPOR) is activated by ligand-me
111                   Notably, we found that the erythropoietin receptor (EPOR) is consistently highly ex
112                                          The erythropoietin receptor (EpoR) is essential for erythrob
113                                          The erythropoietin receptor (EpoR) is essential for producti
114                           Here, we show that erythropoietin receptor (EPOR) is hydroxylated on prolin
115                                          The erythropoietin receptor (EpoR) is required for the proli
116                                              Erythropoietin receptor (EPOR) is thought to be activate
117                              We generated an erythropoietin receptor (EpoR) isoform (ER343/401-S3) th
118                    Two distinct forms of the erythropoietin receptor (EPOR) mediate the cellular resp
119   Using myleoid cells expressing a series of erythropoietin receptor (EpoR) mutants, we have demonstr
120 (EPO) regulates erythropoiesis by binding to erythropoietin receptor (Epor) on erythroid progenitor c
121                 The putative presence of the erythropoietin receptor (EpoR) on human cancer cells has
122 generate cells expressing high levels of the erythropoietin receptor (EpoR) or a dominant negative Sm
123                           Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the c
124                             In contrast, the erythropoietin receptor (EpoR) requires only one recepto
125 tions of the cytoplasmic domain of the human erythropoietin receptor (EPOR) result in a dominantly in
126 tial for normal red cell development and for erythropoietin receptor (EpoR) signaling.
127  design of de novo TM proteins targeting the erythropoietin receptor (EpoR) TM domain in a custom bin
128 und and unbound forms, the activation of the erythropoietin receptor (EPOR) was initially proposed to
129                     We found that the 78-kDa erythropoietin receptor (EPOR), a highly modified form o
130 oprotein, gp55, constitutively activates the erythropoietin receptor (EPOR), causing uncontrolled ery
131  Ab12.6, an agonistic human Ab targeting the erythropoietin receptor (EPOR), exhibits several potenti
132 ate receptors, prolactin receptor (PrlR) and erythropoietin receptor (EpoR), respectively.
133  a homodimeric Type I cytokine receptor, the erythropoietin receptor (EpoR), the thrombopoietin recep
134 sly characterized a truncation mutant of the erythropoietin receptor (EpoR), which is associated with
135 erythroid-specific gene expression including erythropoietin receptor (EpoR), which suggests a novel m
136 Spry1 was discovered to be regulated via the erythropoietin receptor (EPOR), with marked EPO-induced
137 served in the content of beta-globin mRNA in erythropoietin receptor (EpoR)-transfected Ba/F3 cells b
138 ony-stimulating factor receptor (G-CSFR) and erythropoietin receptor (EPOR).
139 d with a growth factor receptor, such as the erythropoietin receptor (EpoR).
140 t studies indicate that cancer cells express erythropoietin receptor (EpoR).
141 n (Epo) can generate commitment cues via the erythropoietin receptor (EpoR); specifically, EpoR signa
142 ates growth hormone receptor (GHR-pY595) and erythropoietin receptor (EpoR-pY426) at 1.98 angstrom an
143 agents (ESAs) have been reported to activate erythropoietin receptors (EpoR) on cell types, including
144 n apparent Mr of 55,000 (gp55) that binds to erythropoietin receptors (EpoR) to stimulate erythroblas
145 ein with apparent Mr of 55,000 that binds to erythropoietin receptors (EpoR) to stimulate erythroblas
146 n specifically binds to and activates murine erythropoietin receptors (EpoRs) coexpressed in the same
147  by binding and orientating two cell-surface erythropoietin receptors (EPORs) which trigger an intrac
148                             Mice lacking the erythropoietin receptor exhibit severe anaemia and defec
149                             Mice lacking the erythropoietin receptor exhibit severe anemia and die at
150                                              Erythropoietin receptors expressed in Sf9 cells were ins
151      When we induced Jak2V617F expression in erythropoietin receptor expressing precursor cells, the
152                                              Erythropoietin receptor expression in nonhematopoietic t
153                         In summary, enhanced erythropoietin receptor expression promotes transplanted
154                Here, we report that enhanced erythropoietin receptor expression, as well as exogenous
155 poietin expression and a tenfold increase in erythropoietin receptor expression, increased cell survi
156 but these cells required coexpression of the erythropoietin receptor for optimal signaling.
157 escribe four different rearrangements of the erythropoietin receptor gene EPOR in Philadelphia chromo
158                          Thus, the truncated erythropoietin receptor gene shows promise as a means fo
159 vates the 3 main myeloid cytokine receptors (erythropoietin receptor, granulocyte colony-stimulating
160                              Mutation of the erythropoietin receptor has been demonstrated to cause f
161 ermal growth factor receptor (ErbB1) and the erythropoietin receptor have indicated that interactions
162 lls, retroviral vectors containing the human erythropoietin receptor (hEpoR) gene were used to transd
163 d property of all EMAs, to bind on the human erythropoietin receptor (hEPOR), is therefore exploited.
164                            For a hypomorphic erythropoietin receptor-HM allele, major defects in eryt
165           Our labs recently engineered novel erythropoietin receptor-IFN chimeric receptors, and we h
166 onstrated a novel role of erythropoietin and erythropoietin receptor in cardiac development in vivo.
167 ty, and when overexpressed together with the erythropoietin receptor in cells, it caused hyperactivat
168 t-derived growth factor beta receptor or the erythropoietin receptor in cultured mouse cells, resulti
169  regulation in the liver and associates with erythropoietin receptor in erythroid cells.
170                    Expression of a truncated erythropoietin receptor in hematopoietic stem cells has
171 compounds that can cause dimerization of the erythropoietin receptor in solution.
172              Analysis of the distribution of erythropoietin receptors in Sf9 plasma membrane and cyto
173  basic science studies on erythropoietin and erythropoietin receptors in solid cancers, raise concern
174                                  Solubilized erythropoietin receptors in whole-cell lysates and isola
175 totic pathways, potentially activated by the erythropoietin receptor, interact to produce the remarka
176  The spectrum of progenitors targeted by the erythropoietin receptor is broader during stress than du
177                            Activation of the erythropoietin receptor is essential for the survival, p
178                                We found that erythropoietin receptor is expressed in the developing m
179 SPCs) can recreate the truncated form of the erythropoietin receptor, leading to substantial increase
180 f Tyr(985) does not alter STAT3 signaling by erythropoietin receptor-LRb (ELR) chimeras in transfecte
181 te is regulated at least in part through the erythropoietin receptor-mediated survival of splenic ear
182 in of SHP-1 with the tyrosine phosphorylated erythropoietin receptor modestly potentiated but was not
183                      Erythropoietin(-/-) and erythropoietin receptor(-/-) mouse embryos die around em
184 and beta common (beta c), whereas the normal erythropoietin receptor (nEpoR) comprises only one known
185 oetal liver, endocardium and myocardium, the erythropoietin receptor null mouse shows extensive apopt
186 esis and other organ defects observed in the erythropoietin receptor null mouse.
187 osis in fetal liver, heart, and brain in the erythropoietin receptor null phenotype was markedly redu
188 iously demonstrated expression of endogenous erythropoietin receptor on murine myoblasts, and erythro
189   Erythropoietin induces dimerization of the erythropoietin receptor on the surface of erythroid prog
190 ve agent that does not bind to the classical erythropoietin receptor or affect hematocrit.
191 cal and suggests that studying modulation of erythropoietin receptor pathway may lead to strategies i
192 een focus forming virus, which activates the erythropoietin receptor; polyoma virus middle T antigen,
193                                              Erythropoietin receptors produced in Sf9 cells could be
194                      Possible erythropoietin/erythropoietin receptor proerythroblast stage specific e
195                                              Erythropoietin receptor protein production was maximal 4
196                                    Mice with erythropoietin receptor restricted to hematopoietic tiss
197  of C2C12 myoblasts overexpressing truncated erythropoietin receptor showed more transplanted cell in
198 system restores active hematopoiesis via the erythropoietin receptor/signal transducer and activator
199                               During stress, erythropoietin receptor signaling downregulates erythrob
200                                     However, erythropoietin receptor signaling has been mostly studie
201 kemia cell lines and enhances ligand-induced erythropoietin receptor signaling in erythroid progenito
202 ment with lenalidomide (LEN), which augments erythropoietin receptor signaling in vitro, can restore
203                 Further, the requirement for erythropoietin receptor signaling is more stringent duri
204                       This work reveals that erythropoietin receptor/Stat5 pathway contributes to BMM
205            Animals expressing only the human erythropoietin receptor survived through adulthood with
206 port the design and validation of two mutant erythropoietin receptors that probe the role of individu
207 se coding for alpha-globin, beta-globin, the erythropoietin receptor, the erythroid krupple-like fact
208 e kinases activated during engagement of the erythropoietin receptor, the Janus family kinase Jak-2 a
209 everal type I cytokine receptors, namely the erythropoietin receptor, the thrombopoietin receptor (Tp
210 trates of these kinases are tyrosines in the erythropoietin receptors themselves and the signal trans
211 iation (erythropoiesis), and truncated human erythropoietin receptors (thEpoR) have been reported in
212 cades are activated during engagement of the erythropoietin receptor to mediate the biological effect
213 ered to be refractory (the IL-6, leptin, and erythropoietin receptors), to suppressor of cytokine sig
214 revious study, it was found that a truncated erythropoietin receptor transgene (tEpoR tg) enables mul
215 n erythropoietin receptor and that the human erythropoietin receptor transgene is able to provide spe
216   This phenotype can be rescued by the human erythropoietin receptor transgene.
217 c defect associated with embryos lacking the erythropoietin receptor was corrected and the increased
218                       The full-length murine erythropoietin receptor was expressed in Spodoptera frug
219 these same samples, erythroid-specific mRNA (erythropoietin receptor) was also detected.
220 dentification of compounds that can dimerize erythropoietin receptor, we have developed a novel, high
221 corresponding to the extracellular domain of erythropoietin receptor were expressed in Escherichia co
222 teracting residues in the growth hormone and erythropoietin receptors, whereas Cys-161, Cys-210, and
223         Transplantation of a region from the erythropoietin receptor, which contains a docking site f
224 of 100 mutants within the WSXWS motif of the erythropoietin receptor, which represents all single ami
225 ng the expression of the cDNA of a truncated erythropoietin receptor with a previously reported genom

 
Page Top